Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-05-31
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
NCT00828542
Postpartum Etonogestrel Implant for Adolescents
NCT01666912
Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
NCT03585504
The Amenorrhea With Etonogestrel Implant
NCT05040282
Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
NCT00847587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Furthermore, lactation and hormonal changes postpartum may modify the bleeding patterns in women using Implanon, with breastfeeding women experiencing a higher likelihood of amenorrhea due to prolactin-induced suppression of ovulation.
* This study aims to fill these gaps by systematically comparing menstrual outcomes based on timing of Implanon insertion postpartum
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implanon (Etonogestrel)
implanon is a long acting ,reversible contraceptive implants used to prevent pregnancy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No contraindications to hormonal contraception.
Exclusion Criteria
* Use of other hormonal contraceptives during the study period.
* Postpartum complications such as severe infections or retained products of conception
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kholoud Khalid Kamal
OBSTETRICS AND GYNECOLOGY RESIDENT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AHMED MOHAMED ABBAS, PROF.DR
Role: STUDY_CHAIR
Assiut University
MOHAMED SAYED ABDELLAH, PROF.DR
Role: STUDY_CHAIR
Assiut University
ALAA AHMED MAKHLOUF, DR
Role: STUDY_CHAIR
Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M, Stewart K, Hussainy S. Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust. 2012 Jul 16;197(2):110-4. doi: 10.5694/mja11.11599.
Richters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: contraceptive practices among a representative sample of women. Aust N Z J Public Health. 2003;27(2):210-6. doi: 10.1111/j.1467-842x.2003.tb00810.x.
. Product information: Implanon NXT, Schering-Plough Pty Ltd, 12 November 2010
Product information: Implanon® Implant, Organon (Australia) Pty Ltd, 19 March 2008.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
effect of implanon
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.